LDLR and hypoalphalipoproteinemia: In keeping with its presumed role in hypoalphalipoproteinemia, Znf202 overexpression led to a marked reduction in HDL-cholesterol both in WT and in Ldlr−/− mice (−63% and −70% respectively).